Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy

(E-pub Ahead of Print)

Author(s): Armita Mahdavi Gorabi, Mohsen Ghanbari, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar*

Journal Name: Current Drug Targets

Become EABM
Become Reviewer
Call for Editor


MicroRNAs (miRNAs) are non-coding RNAs containing around 22 nucleotides, which are expressed in vertebrates and plants. They act as posttranscriptional gene expression regulators, fine-tuning various biological processes in different cell types. There is emerging evidence on their role in different stages of atherosclerosis. In addition to regulating the inflammatory cells involved in atherosclerosis, miRNAs play fundamental roles in the pathophysiology of atherosclerosis such as endothelial cell (EC) dysfunction, the aberrant function of the vascular smooth muscle cell (VSMC) and cholesterol metabolism. Moreover, miRNAs participate in several pathogenic pathways of atherosclerotic plaque development, including their effects on immune cell signaling receptors and lipid uptake. In this study, we review our current knowledge of the regulatory role of miRNAs in various pathogenic pathways underlying atherosclerosis development and also outline potential clinical applications of miRNAs in atherosclerosis.

Keywords: MicroRNA, Atherosclerosis, Inflammation, Clinical application, Immune cells

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 20 January, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1389450122666210120143450
Price: $95

Article Metrics

PDF: 141